Wetness Sensing System

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

56 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-06-08

Study Completion Date

2022-06-29

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The investigational product to be evaluated in this study is FitRight® ConnectTM Wetness Sensing System which includes: the FitRight® ConnectTM Pod, the FitRight® ConnectTM App, the FitRight® ConnectTM charger/adapter and the FitRight® ConnectTM Sensing Brief-(Medline Industries, LP) henceforth, referred to as FitRight® System, Pod, App, Charger, Alert Indicator and Brief. The purpose of this study is to validate the FitRight System sensor's ability to detect when an adult brief has absorbed enough liquid (\~90-360 milliliters (mL)) normal saline via simulated urinary void to trigger an alert to change the brief.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

This Study Will Collect Clinical and Patient Reported Experience Data From Participants Requiring Urine Output Management Overnight in the Home Setting.

NCT06666426

Adult Nocturnal Enuresis Urinary Incontinence (UI)

COMPLETED NA

Development of Applications of the Given® Diagnostic System and Evaluation of Their Performance

NCT00949208

Healthy

COMPLETED

A Trial of effectIveness of a Smart Sensor for Continence Care: the ARCTICC Study

NCT02511314

Urinary Incontinence

COMPLETED NA

An Assessment of the Zephyr BioPatch and Its Ability to Monitor Patient Position

NCT02548624

Patient Positioning Monitoring, Physiologic Pressure Ulcer

WITHDRAWN

Pivotal Study of the Al-Sense Study Protocol

NCT00604838

Amniotic Fluid Leakage

COMPLETED PHASE1/PHASE2

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Each participant will be provided with the FitRight® System for the duration of the study. The study products will be used to collect real-life measurement data in order to assess the FitRight® System. Each participant will be asked to wear at least three briefs so that they are wearing each brief during the simulated voids performed by the site staff. The site staff will perform the simulated void by addition of (90-360 mL normal saline to the brief. The FitRight® System will be assessed for alerts while participants are in the following positions: supine, sitting, and laying on either left or right side. Each participant will be randomized to either the left or right side. Twenty-two of the fifty-six participants will perform rewet testing procedures. The study results will be used to assess the reliability of the device's absorption to trigger an alert

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

System Validation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

All

Each participant will be provided with the FitRight ® System for the duration of the study. The study products will be used to collect real-life measurement data in order to assess the FitRight® System.

Group Type OTHER

Wetness Sensing System Validation

Intervention Type DEVICE

Participants will use the Wetness Sensing System in a simulated setting in the sitting, supine and side position (participants are randomized to either the left or right side position).

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Wetness Sensing System Validation

Participants will use the Wetness Sensing System in a simulated setting in the sitting, supine and side position (participants are randomized to either the left or right side position).

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Individuals at least18 years of age
* Individual can dress and undress self with no assistance
* Individuals can ambulate without assistance
* Individual can sit unsupported in a chair or on bedside with no assistance
* Individual can lay supine and propel self up with no assistance
* Individual can lie left/right lateral and propel self up with no assistance
* Individuals who have hip dimensions between 32" and 70" (81-178 cm

Exclusion Criteria

* Individual is sensitive to the components of the study product(s).
* Individual is considered inappropriate by the Principal Investigator (PI).
* Individual has self-reported current skin condition(s) or issues around the sacral or perineal areas, such as open sores, sacral pressure injuries, rash, burns, surgical wounds and/or compromise of skin integrity.
* Individuals who cannot complete all phases of the study requirements.
* Individual requires use of an absorbent undergarment or catheter as the primary incontinence management strategy
* Individuals who are pregnant

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes